MicroPhage has appointed Don Mooney as the new chief executive officer of the company, effective 3 February 2011.

Don is an experienced leader in clinical diagnostics who served as president and CEO of ProteoGenix, an early stage diagnostics company developing products in the fetal-maternal market.

Prior to ProteoGenix, Don served as vice president and chief operating officer for Focus Diagnostics, an infectious disease company with both laboratory services and global diagnostic products.

Don helped to engineer the acquisition of Focus by Quest Diagnostics in July 2006.

MicroPhage executive chairman of the board Gary Mesch said the board selected Don on the basis of his diagnostics experience and leadership abilities in launching new products, handling regulatory issues and creating effective strategic partnerships.

"Don seems to fit very well with the MicroPhage team and brings strong decision-making skills and vision to guide the company through these next critical months and years as we commercialize the business. We are very pleased that he has chosen to join the team," Mesch said.